Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398502 · ClinicalTrials.gov registry record · Phase 1
Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone
A Phase 1 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00398502: Completed Phase 1 study, sponsored by Bausch Health Americas.
NCT00398502 is a Phase 1 study that has completed, run by Bausch Health Americas. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00398502, a Phase 1 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Primary: To determine the relative bioavailability of MOA-728, an investigational drug, administered orally in both the capsule and tablet formulations to methadone maintenance subjects.Secondary: To assess the pharmacodynamic effect of MOA-728 administered both orally and subcutaneously to methadone maintenance subjects using the oral-cecal transit time.
Interventions
- DRUG MOA-728
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
What the finished NCT00398502 record still lists
NCT00398502 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which MOA-728 is the first listed.
NCT00398502 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00398502 about?
NCT00398502 is a clinical study titled "Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone". Primary: To determine the relative bioavailability of MOA-728, an investigational drug, administered orally in both the capsule and tablet formulations to methadone maintenance subjects.Secondary: To assess the pharmacodynamic effect of MOA-728 administered both orally and subcutaneously to methadon...
What is the current status of trial NCT00398502?
This trial is currently completed. It is a Phase 1 study. The study started on 2006-10. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00398502?
The interventions under investigation include: MOA-728 (DRUG).
Who is sponsoring clinical trial NCT00398502?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia